Nancy Sajjadi will attend the Workshop for the Identification and Standardization of Methods for Assessing Gene Therapy Product Activity and Comparability and the Evaluation of T-Cell Therapies. The Standards Coordinating Body (SCB) for Regenerative Medicine, and the U.S. Food and Drug Administration (FDA) are holding the workshop, which is co-organized by the United States Pharmacopeia (USP). The workshop will be held at the USP headquarters in Rockville, Maryland.